Company intelligence / Profile preview

Pharmaluce

Ownership: Private
Development stage: Other

Overview

Pharmaluce produces and markets a range of high-quality food supplements and medical devices, with products aimed at prevention and support in diseases with significant social impact such as hypertension, diabetes, obesity, mood disorders, and insomnia. The company operates internationally in over 60 countries. Clinical results are not directly reported as the company focuses on supplements/devices rather than pharmaceuticals requiring clinical trials.

Therapeutic areas: PsychiatryEndocrinologyCardiovascularOther
Modalities: Food supplementMedical device
Industry: Food & Nutrition

Beyond the preview

Go deeper on Pharmaluce.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pharmaluce.

Explore the full profile